EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cardiovascular involvement in COVID-19: A review

Zudi Osmani, Rusmir Baljic, Alen Dzubur, Nesina Avdagic, Amela Begic, Refet Gojak, Anja Zuzul, Vladimir Krajinovic

Medical Research Archives · 26.02.2025 · 13 (2)

DOI: 10.18103/mra.v13i2.6208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 26.02.2025. Verfasst von Zudi Osmani und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has underscored the significant role of cardiovascular risk factors in determining the severity and outcomes of the disease. Pre-existing conditions such as hypertension, diabetes, obesity, and cardiovascular diseases have emerged as key contributors to increased susceptibility to severe forms of COVID-19, influencing both short-term and long-term health outcomes. This review examines the complex interplay between these risk factors and the virus’s direct impact on the cardiovascular system. Key findings suggest that conditions like hypertension, diabetes, and obesity not only predispose individuals to more severe disease but also exacerbate complications such as myocardial injury, arrhythmias, and heart failure. Furthermore, the long-term cardiovascular effects of COVID-19, including myocarditis and pericarditis, are of growing concern, particularly in patients with pre-existing cardiovascular conditions. The virus’s ability to induce myocardial damage through mechanisms involving ACE2 receptor binding and inflammatory cytokine storms has been well-documented. The pandemic has also highlighted significant cardiovascular complications, including left and right ventricular dysfunction, myocardial injury, and elevated pulmonary arterial pressure, with the right ventricle being particularly affected due to pulmonary damage. Imaging modalities such as echocardiography and cardiac magnetic resonance have proven valuable for diagnosing myocardial injury and complications, although accessibility may be limited in routine clinical practice. Survivors of severe COVID-19, especially those with pre-existing cardiovascular conditions, face an elevated risk of major adverse cardiovascular events for up to two years post-infection. Evaluation of post-COVID patients includes ECGs, laboratory tests, echocardiography, and cardiac MRI, which provide critical insights into myocardial injury and complications. Preventive measures, including vaccination, regular monitoring of cardiovascular health, and lifestyle modifications, play a crucial role in reducing the long-term risk of cardiovascular complications. The role of vaccination in mitigating the risk of severe disease and cardiovascular complications is well-established, despite rare cases of vaccine-related myocarditis. Understanding these interactions is essential for developing targeted management strategies, improving patient outcomes in both acute and long-term COVID-19 effects, and addressing the broader challenges posed by COVID-19’s impact on cardiovascular health.

Zitieren

APA

Osmani, Z., Baljic, R., Dzubur, A., Avdagic, N., Begic, A., Gojak, R., Zuzul, A., & Krajinovic, V. (2025). Cardiovascular involvement in COVID-19: A review. Medical Research Archives, 13(2). https://doi.org/10.18103/mra.v13i2.6208

Vancouver

Osmani Z, Baljic R, Dzubur A, Avdagic N, Begic A, Gojak R, et al. Cardiovascular involvement in COVID-19: A review. Medical Research Archives. 2025;13(2). doi:10.18103/mra.v13i2.6208

BibTeX
@article{Osmani2025,
  author = {Osmani, Zudi and Baljic, Rusmir and Dzubur, Alen and Avdagic, Nesina and Begic, Amela and Gojak, Refet and Zuzul, Anja and Krajinovic, Vladimir},
  title = {Cardiovascular involvement in COVID-19: A review},
  journal = {Medical Research Archives},
  year = {2025},
  volume = {13},
  number = {2},
  doi = {10.18103/mra.v13i2.6208}
}
Kostenlos starten →